newsfilter
← Latest News
GlobeNewswire·

Albireo to Present Late Breaking Bylvay® (odevixibat) Data at AASLD 2022

– Oral late breaker with new results from positive Phase 3 ASSERT study in Alagille syndrome (ALGS) – Oral late breaker provides evidence of disease modification in PFIC – Analysis of PEDFIC 1 data showed